or Try an Advanced Search...

    ETF Components for BIS - ProShares UltraShort Nasdaq Biotechnology


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    AMGN D 0.04 8.14
    GILD A 6.77 7.41
    VRTX B 1.78 7.21
    BIIB F -0.28 6.12
    ILMN A 2.19 5.67
    REGN F 0.96 4.13
    INCY A 1.72 2.09
    BMRN F 1.19 1.91
    ALNY C -0.29 1.60
    VTRS B 9.09 1.35
    SNY D 0.92 1.29
    NBIX C -1.05 1.16
    SRPT D -5.90 1.15
    NVCR C -2.49 1.10
    JAZZ B 6.75 1.03
    TECH C 0.78 1.02
    IONS F -1.49 1.02
    GH C 13.05 0.96
    AMRN F -2.84 0.85
    MRNA F -2.95 0.83
    BGNE D 2.02 0.83
    ACAD D 8.93 0.81
    ASND F -2.17 0.77
    EXEL A 0.82 0.73
    ARWR D 0.23 0.65
    BLUE F -13.04 0.65
    BBIO F 1.05 0.51
    ALLK C -4.26 0.49
    UTHR A 1.28 0.49
    NKTR C -1.44 0.48
    SAGE F 6.22 0.48
    BPMC C 1.77 0.48
    FGEN F 0.77 0.47
    AGIO A 6.76 0.43
    CRSP C 2.29 0.42
    RARE D -0.18 0.42
    ADPT B -2.09 0.42
    MEDP D -1.35 0.40
    PTCT B -0.51 0.40
    ARGX B 0.42 0.40
    AXSM C -0.30 0.38
    ALLO C -0.93 0.37
    GRFS C 4.97 0.36
    IOVA C 1.15 0.36
    ALKS C -1.09 0.36
    KOD C 1.05 0.35
    HALO C -1.62 0.35
    QURE C 3.77 0.35
    FOLD D -2.31 0.32
    APLS F -0.31 0.31
    XNCR C 2.20 0.26
    MYGN F 0.57 0.26
    DNLI C 0.17 0.26
    ZLAB C 1.68 0.24
    IRWD D -7.54 0.24
    ARVN C -0.86 0.24
    INSM D -1.61 0.23
    FATE F -8.60 0.23
    PCRX D 0.17 0.22
    GLPG F 1.70 0.22
    ITCI B 1.20 0.21
    RGNX D 18.66 0.21
    ESPR C -4.52 0.19
    EDIT F -3.35 0.19
    LGND A 11.12 0.19
    INVA B 0.40 0.18
    VCYT B 2.05 0.18
    ALEC C 7.63 0.18
    TBPH C 0.46 0.17
    YMAB C -0.89 0.16
    CHRS F 13.29 0.16
    HCM C 2.02 0.15
    SUPN B -3.58 0.15

    Represented by ETF Holdings

    Keywords: Biopharmaceutical Biotechnology Medicine Cancer Life Sciences Clinical Development Biology Pain Immunology Infectious Diseases S&P 500 Disease Genetics Immune System Inflammation Nasdaq 100 Organ Systems Cholesterol Monoclonal Antibodies Monoclonal Antibody
    Industries: Biotechnology Drug Manufacturers - Major Diagnostics & Research Drug Manufacturers - Specialty & Generic Medical Instruments & Supplies

    Recent News for ProShares UltraShort Nasdaq Biotechnology & its Holdings

    Date Stock Title
    Nov 7 TECH 9 Stocks To Watch: Financial Sector Outshines Tech In 2024 As 'Trump Trade' Sparks M&A Optimism
    Nov 7 ESPR Esperion Therapeutics, Inc. (ESPR) Q3 2024 Earnings Call Transcript
    Nov 7 IONS A Glimpse Into The Expert Outlook On Ionis Pharmaceuticals Through 5 Analysts
    Nov 7 GH HubSpot Posts Better-Than-Expected Results, Joins Under Armour, Lyft, Wolverine World Wide, Zillow And Other Big Stocks Moving Higher On Thursday
    Nov 7 ESPR Esperion's Q3 Loss Wider Than Expected, Revenues Rise Y/Y
    Nov 7 FOLD Amicus' Q3 Earnings & Revenues Beat Estimates, '24 View Updated
    Nov 7 TECH Taiwan Semi and GlobalFoundries Finalize Major US Funding Deals, Eye Growth in Chip Manufacturing
    Nov 7 MRNA 2025 will be 'fairly challenging year' for Moderna: Analyst
    Nov 7 NKTR Nektar and Collaborators Present Late-breaking Results from Phase 2 Study of NKTR-255 for the Treatment of Radiation Induced Lymphopenia in Locally Advanced Non-Small Cell Lung Cancer Patients at Society for Immunotherapy of Cancer (SITC) Annual Meeting
    Nov 7 PCRX Pacira Q3 Earnings Top, Revenues Miss Despite Exparel Sales Growth
    Nov 7 VCYT Veracyte Inc (VCYT) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Outlook
    Nov 7 ALLO Allogene Therapeutics Announces Positive Phase 1 Data Demonstrating the Potential of ALLO-316 in Heavily Pretreated Patients with Advanced Renal Cell Carcinoma at SITC and IKCS
    Nov 7 FOLD Here's Why Amicus Therapeutics (FOLD) is a Strong Momentum Stock
    Nov 7 BMRN Here’s Why BioMarin Aristotle Large Cap Growth Strategy Divested From Pharmaceutical (BMRN)
    Nov 7 MRNA Moderna Sales Get Lift From Early Nod for Newest Covid Shot
    Nov 7 ILMN Interpreting Illumina (ILMN) International Revenue Trends
    Nov 7 TECH Top 3 Tech Stocks You'll Regret Missing In November
    Nov 7 MRNA Moderna Surges After Crushing Sales Forecasts, Reiterating Its Outlook
    Nov 7 MRNA Moderna Stock Jumps on Better-Than-Expected Covid-19 Vaccine Sales
    Nov 7 MRNA Moderna, Inc. 2024 Q3 - Results - Earnings Call Presentation
    The investment seeks daily investment results that correspond to two times the inverse (-2x) of the daily performance of the Nasdaq Biotechnology Index®. The fund invests in derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times the inverse (-2x) of the daily return of the index. The index is a modified capitalization weighted index that includes securities of NASDAQ listed companies that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark ("ICB") which also meet other eligibility criteria determined by NASDAQ. It is non-diversified.
    Exchange Traded Fund ETF Exchange Traded Funds Biotechnology Leveraged ETF Ultra ETF Inverse ETF Bear Market ETF Industry Classification Nasdaq Biotechnology Index Nasdaq Biotech Nasdaq Biotechnology Total Return Index
    Back to the Main BIS Page...